EX-1
from 8-K
1 page
March 18, 1999 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 Gentlemen: We Have Read Item 4 of Form 8-K Dated March 18, 1999, of Electropharmacology, Inc. and Are in Agreement With the Statements Contained in the First, Third, Fifth and Sixth Paragraphs on Page One Therein. We Have No Basis to Agree or Disagree With Other Statements of the Registrant Contained Therein. Ernst & Young Llp Copy to Dr. Arup Sen Chairman and Chief Executive Officer Electropharmacology, Inc
12/34/56
